display
EU Council President Charles Michel has warned the manufacturers of corona vaccines of possible consequences in view of delivery delays.
"We expect that the contracts confirmed by the pharmaceutical companies will be adhered to," Michel told the French broadcaster Europe 1 on Sunday. The EU could also use "legal means" to ensure compliance with the contracts.
You understand that there can be problems, said Michel.
But it needs clarity about the reasons.
Pfizer initially announced delays in vaccine deliveries of several weeks.
After hitting the table with your fist, it was only about a week.
After the pharmaceutical company cooperation between Biontech and Pfizer, the manufacturer Astrazeneca also announced on Friday that it would temporarily be able to deliver less vaccine than originally planned.
The reason is lower production at one location in the European supply chain, it said.
According to information from the EU Commission, there will now be another meeting of the steering committee on the EU vaccination strategy on the delays this Monday.
display
The Brussels authority actually assumes that the member states will be able to vaccinate at least 70 percent of the adult population with the vaccines it has bought by the end of the summer.
EU Council President Charles Michel admitted on Sunday that this goal would be difficult to achieve.
The Anglo-Swedish company Astrazeneca developed its vaccine together with the University of Oxford.
It is already in use in the UK.
Approval in the European Union is also expected this week.